- Home
- SIG vs VCEL Comparison
SIG vs VCEL Comparison
Compare SIG & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- VCEL
- Stock Information
- Founded
- SIG 1950
- VCEL 1989
- Country
- SIG Bermuda
- VCEL United States
- Employees
- SIG N/A
- VCEL N/A
- Industry
- SIG Consumer Specialties
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIG Consumer Discretionary
- VCEL Health Care
- Exchange
- SIG Nasdaq
- VCEL Nasdaq
- Market Cap
- SIG 2.2B
- VCEL 2.1B
- IPO Year
- SIG N/A
- VCEL 1997
- Fundamental
- Price
- SIG $64.40
- VCEL $41.73
- Analyst Decision
- SIG Buy
- VCEL Strong Buy
- Analyst Count
- SIG 4
- VCEL 8
- Target Price
- SIG $69.00
- VCEL $61.75
- AVG Volume (30 Days)
- SIG 935.2K
- VCEL 548.2K
- Earning Date
- SIG 06-03-2025
- VCEL 05-08-2025
- Dividend Yield
- SIG 1.99%
- VCEL N/A
- EPS Growth
- SIG N/A
- VCEL 521.85
- EPS
- SIG N/A
- VCEL 0.05
- Revenue
- SIG $6,703,800,000.00
- VCEL $238,541,000.00
- Revenue This Year
- SIG $0.64
- VCEL $23.23
- Revenue Next Year
- SIG $1.26
- VCEL $24.41
- P/E Ratio
- SIG N/A
- VCEL $705.44
- Revenue Growth
- SIG N/A
- VCEL 14.80
- 52 Week Low
- SIG $45.55
- VCEL $37.39
- 52 Week High
- SIG $112.06
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- SIG 65.50
- VCEL 51.56
- Support Level
- SIG $59.90
- VCEL $37.48
- Resistance Level
- SIG $65.62
- VCEL $39.42
- Average True Range (ATR)
- SIG 2.25
- VCEL 1.84
- MACD
- SIG 0.59
- VCEL 0.57
- Stochastic Oscillator
- SIG 90.15
- VCEL 77.71
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.